Amended Statement of Beneficial Ownership (sc 13d/a)
June 09 2020 - 4:46PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED
IN STATEMENTS FILED PURSUANT
TO § 240.13d-1(a)
AND AMENDMENTS THERETO FILED PURSUANT TO
§ 240.13d-2(a)
(Amendment No. 1)1
Castlight Health, Inc.
(Name
of Issuer)
Class B Common Stock, par value $0.0001
(Title of Class of Securities)
14862Q 10 0
(CUSIP Number)
STEVE WOLOSKY, ESQ.
OLSHAN FROME WOLOSKY LLP
1325 Avenue of the Americas
New York, New York 10019
(212)
451-2300
(Name, Address and Telephone Number of Person
Authorized to Receive Notices
and Communications)
June 9, 2020
(Date of Event Which Requires
Filing of This Statement)
If
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule
13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following
box ☒.
Note: Schedules
filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See
§ 240.13d-7 for other parties to whom copies are to be sent.
1
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided
in a prior cover page.
The information required
on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
|
|
|
|
|
|
|
|
|
|
|
Raging Capital Management, LLC
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) ☐
|
|
|
|
|
(b) ☐
|
|
|
|
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
SOURCE OF FUNDS
|
|
|
|
|
|
|
|
|
|
|
AF
|
|
|
5
|
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
6
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
|
|
|
|
|
|
|
DELAWARE
|
|
NUMBER OF
|
|
7
|
|
SOLE VOTING POWER
|
|
SHARES
|
|
|
|
|
|
BENEFICIALLY
|
|
|
|
|
- 0 -
|
|
OWNED BY
|
|
8
|
|
SHARED VOTING POWER
|
|
EACH
|
|
|
|
|
|
REPORTING
|
|
|
|
|
10,423,517
|
|
PERSON WITH
|
|
9
|
|
SOLE DISPOSITIVE POWER
|
|
|
|
|
|
|
|
|
|
|
|
|
- 0 -
|
|
|
|
10
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
|
|
|
|
|
|
|
10,423,517
|
|
|
11
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
|
|
|
|
|
|
|
10,423,517
|
|
|
12
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
13
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
|
|
|
|
|
|
|
|
9.1%
|
|
|
14
|
|
TYPE OF REPORTING PERSON
|
|
|
|
|
|
|
|
|
|
|
IA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
|
|
|
|
|
|
|
|
|
|
|
William C. Martin
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) ☐
|
|
|
|
|
(b) ☐
|
|
|
|
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
SOURCE OF FUNDS
|
|
|
|
|
|
|
|
|
|
|
AF, PF
|
|
|
5
|
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
6
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
|
|
|
|
|
|
|
USA
|
|
NUMBER OF
|
|
7
|
|
SOLE VOTING POWER
|
|
SHARES
|
|
|
|
|
|
BENEFICIALLY
|
|
|
|
|
605,000
|
|
OWNED BY
|
|
8
|
|
SHARED VOTING POWER
|
|
EACH
|
|
|
|
|
|
REPORTING
|
|
|
|
|
10,423,517
|
|
PERSON WITH
|
|
9
|
|
SOLE DISPOSITIVE POWER
|
|
|
|
|
|
|
|
|
|
|
|
|
605,000
|
|
|
|
10
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
|
|
|
|
|
|
|
10,423,517
|
|
|
11
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
|
|
|
|
|
|
|
11,028,517
|
|
|
12
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
13
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
|
|
|
|
|
|
|
|
9.6%
|
|
|
14
|
|
TYPE OF REPORTING PERSON
|
|
|
|
|
|
|
|
|
|
|
HC
|
|
The following constitutes
Amendment No. 1 to the Schedule 13D filed by the undersigned (“Amendment No. 1”). This Amendment No. 1 amends the Schedule
13D as specifically set forth herein.
|
Item 2.
|
Identity and Background.
|
The final paragraph
of Item 2(a) is hereby amended and restated to read as follows:
Set forth on Schedule
A annexed to this Amendment No. 1 (“Schedule A”) is the name and present principal business, occupation
or employment and the name, principal business and address of any corporation or other organization in which such employment is
conducted of the executive officers of Raging Capital. To the best of the Reporting Persons’ knowledge, except as otherwise
set forth herein, none of the persons listed on Schedule A beneficially owns any securities of the Issuer or is a party
to any contract, agreement or understanding required to be disclosed herein.
|
Item 3.
|
Source and Amount of Funds or Other Consideration.
|
Item 3 is hereby amended
and restated to read as follows:
The aggregate purchase
price of the 10,423,517 Shares owned directly by Raging Master is approximately $14,834,429, including brokerage commissions. Such
Shares were acquired with the working capital of Raging Master.
The aggregate purchase
price of the 605,000 Shares beneficially owned directly by Mr. Martin is approximately $411,561, including brokerage commissions.
Such Shares were acquired with personal funds.
Raging Master effects
purchases of securities primarily through margin accounts maintained for it with prime brokers, which may extend margin credit
to it as and when required to open or carry positions in the margin accounts, subject to applicable federal margin regulations,
stock exchange rules and the prime brokers’ credit policies. In such instances, the positions held in the margin accounts
are pledged as collateral security for the repayment of debit balances in the accounts.
|
Item 4.
|
Purpose of Transaction.
|
Item 4 is hereby amended
to add the following:
On June 9, 2020, Raging
Capital sent a letter to the board of directors of the Issuer (the “June letter”) following up on a private letter
previously sent to the board in April 2020 (the “April letter”) expressing its serious concerns regarding the lack
of cost consciousness and profitability at the Issuer and imploring the board to take decisive action to address these concerns.
Although Raging Capital was pleased to see some of the incremental cost cuts announced by the Issuer after the April letter was
sent, Raging Capital expressed its surprise and disappointment that none of the board members reached out to it, as specifically
requested, to discuss an action plan that could be immediately implemented by the Issuer. Raging Capital also discussed the alarming
results of the recent annual meeting of shareholders, including a withhold vote of over 20% of the votes cast on the two independent
directors up for election, more than 23 million shares voted against the appointment of Ernst & Young (“E&Y”)
as the Issuer’s auditor and management’s failure to obtain the requisite vote to approve the non-binding advisory proposal
on executive compensation. Raging Capital encouraged the board to act with a greater sense of urgency to address its concerns or
else risk facing a proxy campaign in the fall. Raging Capital referred the board to its April letter outlining the Issuer’s
egregious cost structure and ideas on how to streamline and rationalize the business in order to drive immediate profitability,
including replacing E&Y.
A copy of the June
letter, including the April letter, are attached hereto as Exhibit 99.1 and incorporated herein by reference.
|
Item 5.
|
Interest in Securities of the Issuer.
|
Items 5(a)-(c) are
hereby amended and restated to read as follows:
(a) The
aggregate percentage of Shares reported owned by each person named herein is based upon 114,484,826 Shares outstanding as of May
5, 2020, which is the total number of Shares outstanding as reported in the Issuer’s Form 10-Q filed with the Securities
and Exchange Commission on May 8, 2020.
As of the close of
business on June 8, 2020, each of Raging Capital and William C. Martin may be deemed to beneficially own the 10,423,517 Shares,
constituting approximately 9.1% of the Shares outstanding, held by Raging Master by virtue of their relationships with Raging Master
discussed in further detail in Item 2. As of the close of business on June 8, 2020, Mr. Martin also directly beneficially owns
an additional 605,000 Shares which, together with the Shares held by Raging Master, constitutes approximately 9.6% of the Shares
outstanding.
The filing of this
Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange
Act of 1934, as amended, the beneficial owners of any Shares he or it does not directly own. Each of the Reporting Persons specifically
disclaims beneficial ownership of the Shares reported herein that he or it does not directly own. Without limiting the foregoing
sentence, Raging Master specifically disclaims beneficial ownership of the securities of the Issuer held by it by virtue of its
inability to vote or dispose of such securities as a result of the IMA.
(b) Raging
Capital and William C. Martin may be deemed to share the power to vote and dispose of the Shares held by Raging Master. Mr. Martin
has the power to vote and dispose of the Shares he directly beneficially owns.
(c) Schedule
B annexed hereto lists all transactions in the Shares during the past sixty days by the Reporting Persons and the other executive
officer of Raging Capital disclosed in Schedule A. All of such transactions were effected in the open market.
|
Item 7.
|
Material to be Filed as Exhibits.
|
Item 7 is hereby amended
to add the following exhibit:
|
99.1
|
Letters to the Board of Directors of Castlight Health, Inc., dated June 9, 2020 and April 21, 2020.
|
SIGNATURES
After reasonable inquiry
and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement
is true, complete and correct.
Dated: June 9, 2020
|
Raging Capital Management, LLC
|
|
|
|
By:
|
/s/ Frederick C. Wasch
|
|
|
Name:
|
Frederick C. Wasch
|
|
|
Title:
|
Chief Financial Officer
|
|
/s/ Frederick C. Wasch
|
|
Frederick C. Wasch as attorney-in-fact for William C. Martin
|
SCHEDULE A
Executive Officers of Raging
Capital Management, LLC
Name and
Position
|
Present
Principal Occupation
|
Business
Address
|
William C. Martin,
Chairman, Chief Investment Officer and Managing Member
|
Chairman, Chief Investment Officer and Managing Member of Raging Capital Management, LLC
|
c/o Raging Capital Management, LLC
Ten Princeton Avenue, P.O. Box 228
Rocky Hill, New Jersey 08553
|
Frederick C. Wasch,
Chief Financial Officer1
|
Chief Financial Officer of Raging Capital Management, LLC
|
c/o Raging Capital Management, LLC
Ten Princeton Avenue, P.O. Box 228
Rocky Hill, New Jersey 08553
|
1As of the close of business on June 8, 2020, Mr. Wasch may be deemed to beneficially own 18,545 Shares, including Shares held by his spouse. The aggregate purchase price of such Shares is approximately $12,980. Such Shares were purchased with personal funds. A list of all transactions in the Shares by Mr. Wasch during the past sixty days are set forth in Schedule B.
SCHEDULE B
Transactions in the Shares of
the Issuer During the Past 60 Days
Class of
Security
|
Shares Purchased/(Sold)
|
Price ($)
|
Date of
Purchase/Sale
|
WILLIAM C. MARTIN
Common Stock
|
50,000
|
0.6750
|
04/20/2020
|
Common Stock
|
12,500
|
0.6750
|
04/20/2020
|
Common Stock
|
12,500
|
0.6750
|
04/20/2020
|
Common Stock
|
25,000
|
0.6560
|
04/21/2020
|
Common Stock
|
12,500
|
0.6560
|
04/21/2020
|
Common Stock
|
12,500
|
0.6560
|
04/21/2020
|
Common Stock
|
25,000
|
0.6560
|
04/21/2020
|
Common Stock
|
100,000
|
0.6580
|
04/22/2020
|
Common Stock
|
50,000
|
0.6880
|
04/24/2020
|
Common Stock
|
50,000
|
0.7210
|
04/27/2020
|
Common Stock
|
35,000
|
0.6310
|
05/05/2020
|
Common Stock
|
10,000
|
0.6310
|
05/05/2020
|
Common Stock
|
10,000
|
0.6310
|
05/05/2020
|
Common Stock
|
50,000
|
0.6310
|
05/05/2020
|
Common Stock
|
50,000
|
0.6310
|
05/05/2020
|
Common Stock
|
7,000
|
0.6310
|
05/06/2020
|
Common Stock
|
(10,000)
|
0.6310
|
05/06/2020
|
Common Stock
|
3,000
|
0.6310
|
05/06/2020
|
Common Stock
|
1,985
|
0.7750
|
05/28/2020
|
Common Stock
|
100
|
0.7750
|
05/28/2020
|
Common Stock
|
800
|
0.7750
|
05/28/2020
|
Common Stock
|
200
|
0.7750
|
05/28/2020
|
Common Stock
|
20,200
|
0.7750
|
05/28/2020
|
Common Stock
|
61
|
0.7750
|
05/28/2020
|
Common Stock
|
16,817
|
0.7750
|
05/28/2020
|
Common Stock
|
55
|
0.7750
|
05/28/2020
|
Common Stock
|
2,939
|
0.7750
|
05/28/2020
|
Common Stock
|
4,643
|
0.7748
|
05/28/2020
|
Common Stock
|
1,700
|
0.7737
|
05/28/2020
|
Common Stock
|
500
|
0.7734
|
05/28/2020
|
Common Stock
|
15,000
|
0.7550
|
05/29/2020
|
Common Stock
|
17,200
|
0.7700
|
06/02/2020
|
Common Stock
|
600
|
0.7700
|
06/02/2020
|
Common Stock
|
1,000
|
0.7685
|
06/02/2020
|
Common Stock
|
100
|
0.7679
|
06/02/2020
|
Common Stock
|
600
|
0.7672
|
06/02/2020
|
Common Stock
|
500
|
0.7671
|
06/02/2020
|
Common Stock
|
8,277
|
0.7700
|
06/03/2020
|
Common Stock
|
400
|
0.7700
|
06/03/2020
|
Common Stock
|
5,124
|
0.7700
|
06/03/2020
|
Common Stock
|
200
|
0.7700
|
06/03/2020
|
Common Stock
|
99
|
0.7700
|
06/03/2020
|
Common Stock
|
200
|
0.7700
|
06/03/2020
|
Common Stock
|
100
|
0.7700
|
06/03/2020
|
Common Stock
|
200
|
0.7700
|
06/03/2020
|
Common Stock
|
100
|
0.7700
|
06/03/2020
|
Common Stock
|
100
|
0.7700
|
06/03/2020
|
Common Stock
|
198
|
0.7700
|
06/03/2020
|
Common Stock
|
2
|
0.7700
|
06/03/2020
|
FREDERICK C. WASCH
Common Stock
|
17,165
|
0.7000
|
04/30/2020
|
Common Stock
|
117
|
0.7200
|
04/30/2020
|
Common Stock
|
200
|
0.7200
|
04/30/2020
|
Common Stock
|
200
|
0.7200
|
04/30/2020
|
Common Stock
|
300
|
0.7300
|
04/30/2020
|
Common Stock
|
5,684
|
0.7300
|
04/30/2020
|
Common Stock
|
1,008
|
0.7200
|
04/30/2020
|
Common Stock
|
372
|
0.6300
|
05/05/2020
|
Common Stock
|
5,992
|
0.7200
|
05/05/2020
|
Common Stock
|
100
|
0.6300
|
05/05/2020
|
Common Stock
|
100
|
0.6300
|
05/05/2020
|
Common Stock
|
200
|
0.6300
|
05/05/2020
|
Castlight Health (NYSE:CSLT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Castlight Health (NYSE:CSLT)
Historical Stock Chart
From Apr 2023 to Apr 2024